Pharmacological evaluation of nasal delivery of selegiline hydrochloride-loaded thiolated chitosan nanoparticles for the treatment of depression

References

• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. 2004. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release.100:5–28.
   PubMed Web of Science ®Google Scholar
• Andlin‐Sobocki P, Jonsson B, Wittchen HU, Olesen J. 2005. Cost of disorders of the brain in Europe. Eur J Neurol. 12:1–27.
   PubMed Web of Science ®Google Scholar
• Bergmeyer HU. 1965. Methods of Enzymatic Analysis. Amsterdam: Elsevier.
   Google Scholar
• Berman SB, Hastings TG. 1999. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria. J Neurochem. 73:1127–1137.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnurch A, Hornof M, Zoidl T. 2003. Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm. 260:229–237.
   PubMed Web of Science ®Google Scholar
• Bhatt R, Singh D, Prakash A, Mishra N. 2014. Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington's disease. Drug Deliv. 1–9.
   Google Scholar
• Boateng JS, Ayensu I. 2014. Preparation and characterization of laminated thiolated chitosan-based freeze-dried wafers for potential buccal delivery of macromolecules. Drug Dev Ind Pharm. 40: 611–618.
   PubMed Web of Science ®Google Scholar
• Byerley WF, Risch SC. 1985. Depression and serotonin metabolismml: rationale for: neurotransmitter precursor treatment. J Clin Psychopharmacol. 5:191–206.
   PubMed Web of Science ®Google Scholar
• Clementi E, Brown GC, Feelisch M, Moncada S. 1998. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci. 95:7631–7636.
   PubMed Web of Science ®Google Scholar
• Davies KJ. 2000. Oxidative stress, antioxidant defenses and damage removal, repair, and replacement systems. IUBMB Life. 50:279–289.
   PubMed Web of Science ®Google Scholar
• Dhanda D, Frey WH II, Leopold D, Kompella UB. 2005. Nose-to-brain delivery: approaches for drug deposition in the human olfactory epithelium. Drug Deliv Technol. 5:64–72.
   Google Scholar
• Ebadi M, Sharma S, Shavali S. 2002. Neuroprotective actions of selegiline. J Neurosci Res. 67:285–289.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Featherstone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:88–95.
   PubMed Web of Science ®Google Scholar
• Fernandez-Urrusuno R, Romani D, Calvo P, Vila-Jato JL. 1999. Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration. Stp Pharma Sci. 9:429–436.
   Google Scholar
• Forlenza MJ, Miller GE. 2006. Increased serum levels of 8-hydroxy-2′-deoxyguanosine in clinical depression. Psychosom Med. 68:1–7.
   PubMed Web of Science ®Google Scholar
• Garcia-Garcia E, Andrieux K, Gil S, Couvreur P. 2005. Colloidal carriers and blood–brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int J Pharm. 298:274–292.
   PubMed Web of Science ®Google Scholar
• Gardner A, Boles RG. 2011. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry. 35:730–743.
   PubMed Web of Science ®Google Scholar
• Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS. 1982. Analysis of nitrate, nitrite, and nitrate in biological fluids. Anal Biochem. 126:131–138.
   PubMed Web of Science ®Google Scholar
• Hawkins J, Hicks RA, Phillips N, Moore JD. 1978. Swimming rats and human depression. Nature. 274:512.
   PubMed Web of Science ®Google Scholar
• He P, Davis SS, Illum L. 1998. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm. 166:75–88.
   Web of Science ®Google Scholar
• Illum L. 2000. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci. 11:1–18.
   PubMed Web of Science ®Google Scholar
• Jezek P, Hlavata L. 2005. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol. 37:2478–2503.
   PubMed Web of Science ®Google Scholar
• Kalonia H, Kumar P, Kumar A, Nehru B. 2009. Effect of caffeic acid and rofecoxib and their combination against intrastriatal quinolinic acid induced oxidative damage, mitochondrial and histological alterations in rats. Inflammopharmacology. 17:211–219.
   PubMedGoogle Scholar
• Kast CE, Valenta C, Leopold M, Bernkop-Schnurch A. 2002. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J Control Release. 81:347–354.
   PubMed Web of Science ®Google Scholar
• Kast CE, Frick W, Losert U, Bernkop-Schnürch A. 2003. Chitosan-thioglycolic acid conjugate: a new scaffold material for tissue engineering? Int J Pharm. 256:183–189.
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Handa T, Kasai A, Takenaka H, Lin S, Ando Y. 1985. Novel method for the preparation of controlled‐release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate–chitosan. J Pharm Sci. 74:264–268.
   PubMed Web of Science ®Google Scholar
• King TE. 1967. Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. Methods Enzymol. 10:322–331.
   Google Scholar
• King TE, Howard RL. 1967. Preparations and properties of soluble NADH dehydrogenases from cardiac muscle. Methods Enzymol. 10:275–294.
   Google Scholar
• Lee DW, Powers K, Baney R. 2004. Physicochemical properties and blood compatibility of acylated chitosan nanoparticles. Carbohydr Polym. 58:371–377.
   Web of Science ®Google Scholar
• Lee DW, Shirley SA, Lockey RF, Mohapatra SS. 2006. Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir Res. 7:112.
   PubMed Web of Science ®Google Scholar
• Liu L-S, Liu S-Q, Ng SY, Froix M, Ohno T, Heller J. 1997a. Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres. J Control Release. 43:65–74.
   Web of Science ®Google Scholar
• Liu Y, Peterson DA, Kimura H, Schubert D. 1997b. Mechanism of cellular 3‐(4, 5‐dimethylthiazol‐2‐yl)‐2, 5‐diphenyltetrazolium bromide (MTT) reduction. J Neurochem. 69:581–593.
   PubMed Web of Science ®Google Scholar
• Maes M, Galecki P, Chang YS, Berk M. 2011. A review on the oxidative and nitrosative stress (O & NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Prog Neuro-Psychopharmacol Biol Psychiatry. 35:676–692.
   PubMed Web of Science ®Google Scholar
• Magyar K, Haberle D. 1998. Neuroprotective and neuronal rescue effects of selegiline: review. Neurobiology (Budapest, Hungary). 7:175–190.
   Google Scholar
• Manjunath K, Venkateswarlu V. 2005. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release. 107:215–228.
   PubMed Web of Science ®Google Scholar
• Ma YP, Ma MM, Ge S. 2007. Intranasally delivered TGF-ß1 enters brain and regulates gene expressions of its receptors in rats. Brain Res Bull. 74:271–277.
   PubMed Web of Science ®Google Scholar
• Milloti G, Laffleur F, Perera G, Vigl C, Pickl K, Sinner F, Bernkop-Schnurch A. 2014. In vivo evaluation of thiolated chitosan tablets for oral insulin delivery. J Pharm Sci 103:3165–3170.
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. 2002. Neurobiology of depression. Neuron. 34:13–25.
   PubMed Web of Science ®Google Scholar
• Ng F, Berk M, Dean O, Bush AI. 2008. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 11:851–876.
   PubMed Web of Science ®Google Scholar
• Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O. 2004. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol. 19:89–95.
   PubMed Web of Science ®Google Scholar
• Porsolt R, Bertin A, Jalfre M. 1977a. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 229:327–336.
   PubMedGoogle Scholar
• Porsolt RD, Le Pichon M, Jalfre M. 1977b. Depression: a new animal model sensitive to antidepressant treatments. Nature. 266:730–732.
   Google Scholar
• Pulliam L, Sun B, Rempel H. 2007. Intranasal Tat alters gene expression in the mouse brain. J Neuroimmune Pharmacol. 2:87–92.
   PubMed Web of Science ®Google Scholar
• Reger MA, Watson GS, Frey WH. 2006. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging. 27:451–458.
   PubMed Web of Science ®Google Scholar
• Rinwa P, Kumar A, Garg S. 2013. Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression. PloS One. 8:e61052.
   PubMed Web of Science ®Google Scholar
• Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. 2007. Major depressive disorder is accompanied with oxidative stress: short‐term antidepressant treatment does not alter oxidative–antioxidative systems. Hum Psychopharmacol. 22:67–73.
   PubMed Web of Science ®Google Scholar
• Shimazu S, Minami A, Kusumoto H, Yoneda F. 2005. Antidepressant-like effects of selegiline in the forced swim test. Eur Neuropsychopharmacol. 15:563–571.
   PubMed Web of Science ®Google Scholar
• Sies H. 1997. Oxidative stress: oxidants and antioxidants. Exp Physiol. 82:291–295.
   PubMed Web of Science ®Google Scholar
• Skelin I, Kovacevic T, Diksic M. 2011. Neurochemical and behavioural changes in rat models of depression. Croat Chem Acta. 84:287–299.
   Web of Science ®Google Scholar
• Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A. 1967. an electron-transport system associated with the outer membrane of liver mitochondria a biochemical and morphological study. J Cell Biol. 32:415–438.
   PubMed Web of Science ®Google Scholar
• Steru L, Chermat R, Thierry B, Simon P. 1985. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 85:367–370.
   PubMed Web of Science ®Google Scholar
• Thorne RG, Emory CR, Ala TA, Frey WH II. 1995. Quantitative analysis of the olfactory vpathway for drug delivery to the brain. Brain Res. 692:278–282.
   PubMed Web of Science ®Google Scholar
• Thorne RG, Pronk GJ, Padmanabhan V, Frey WH II. 2004. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience. 127:481–496.
   PubMed Web of Science ®Google Scholar
• Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA. 2008. Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opin Drug Deliv. 5:155–174.
   PubMed Web of Science ®Google Scholar
• Turrens JF. 2003. Mitochondrial formation of reactive oxygen species. J Physiol. 552:335–344.
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39:44–84.
   PubMed Web of Science ®Google Scholar
• Wills E. 1966. Mechanisms of lipid peroxide formation in animal tissues. Biochem J. 99:667–676.
   PubMed Web of Science ®Google Scholar
• Zhang QZ, Zha LS, Zhang Y. 2006. The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats. J Drug Target. 14:281–290.
   PubMed Web of Science ®Google Scholar
• Zhu X, Su M, Tang S, Wang L, Liang X, Meng F, et al. 2012. Synthesis of thiolated chitosan and preparation nanoparticles with sodium alginate for ocular drug delivery. Mol Vis. 18:1973.
   PubMed Web of Science ®Google Scholar